MEDICALLETTER.ORG KEYWORD DENSITY CHECKER

Total words: 1819 | 2-word phrases: 472 | 3-word phrases: 511 | 4-word phrases: 523

PAGE INFO

Title Try to keep the title under 60 characters (55 characters)
The Medical Letter Home Page | The Medical Letter, Inc.
Description Try to keep the meta description between 50 - 160 characters (95 characters)
The Medical Letter has provided trusted prescription drug information and drug facts since 1959
Keywords Meta keywords are not recommended anymore (95 characters)
drug information, drug facts, prescription drugs
H1 H1 tag on the page (4 characters)
Home

ONE WORD PHRASES 313 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1for237.35%
2the185.75%
3in123.83%
4of92.88%
5a92.88%
6issue72.24%
7only72.24%
8us61.92%
9treatment61.92%
10online61.92%

TWO WORD PHRASES 472 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1online only61.27%
2treatment of61.27%
3the medical51.06%
4is a51.06%
5a new40.85%
6medical letter40.85%
7for treatment30.64%
8is the30.64%
9issue previous30.64%
10the fda30.64%
11complete issue30.64%
12view complete30.64%
13in patients30.64%
14atopic dermatitis30.64%
15approved by20.42%
16by the20.42%
17contact us20.42%
18roflumilast is20.42%
19in a20.42%
20monoclonal antibody20.42%

THREE WORD PHRASES 511 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1the medical letter40.78%
2for treatment of30.59%
3view complete issue30.59%
4glp1 and gipglp120.39%
5only table glp120.39%
6table glp1 and20.39%
7and gipglp1 receptor20.39%
8gipglp1 receptor agonists20.39%
9in the us20.39%
10approved by the20.39%
11by the fda20.39%
12issue previous issue20.39%
13online only table20.39%
14complete issue previous20.39%
15online only view20.39%
16only view complete20.39%
17which can be10.20%
18roflumilast is the10.20%
19is the second10.20%
20in patients ≥310.20%
21the second pde410.20%
22second pde4 inhibitor10.20%
23used in patients10.20%
24be used in10.20%
25can be used10.20%
26crisaborole eucrisa which10.20%
27eucrisa which can10.20%
28ad crisaborole eucrisa10.20%
29of ad crisaborole10.20%
30treatment of ad10.20%

FOUR WORD PHRASES 523 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1view complete issue previous20.38%
2and gipglp1 receptor agonists20.38%
3only view complete issue20.38%
4online only view complete20.38%
5only table glp1 and20.38%
6table glp1 and gipglp120.38%
7glp1 and gipglp1 receptor20.38%
8online only table glp120.38%
9approved by the fda20.38%
10is the second pde410.19%
11– arcutis for topical10.19%
12arcutis for topical treatment10.19%
13approved in the us10.19%
14be approved in the10.19%
15to be approved in10.19%
16inhibitor to be approved10.19%
17pde4 inhibitor to be10.19%
18second pde4 inhibitor to10.19%
19the second pde4 inhibitor10.19%
20roflumilast is the second10.19%
21atopic dermatitis ad in10.19%
22patients ≥6 years old10.19%
23in patients ≥6 years10.19%
24ad in patients ≥610.19%
25in the us for10.19%
26for topical treatment of10.19%
27topical treatment of mild10.19%
28to moderate atopic dermatitis10.19%
29moderate atopic dermatitis ad10.19%
30dermatitis ad in patients10.19%
31home friday august 910.19%
32ad crisaborole eucrisa which10.19%
33treatment of ad crisaborole10.19%
34roflumilast is available as10.19%
35psoriasis and a 0310.19%
36plaque psoriasis and a10.19%
37of plaque psoriasis and10.19%
38treatment of plaque psoriasis10.19%
39for treatment of plaque10.19%
40cream for treatment of10.19%

EXTERNAL LINKS

# URL Whois Check
1https://themedicalletter.m-pages.com/ProductPreferenceSignUp Whoism-pages.com
2 https://www.facebook.com/TheMedLetter Whoisfacebook.com
3 http://twitter.com/MedicalLetter Whoistwitter.com
4 https://www.instagram.com/medicalletter/ Whoisinstagram.com
5 https://www.linkedin.com/company/the-medical-letter-inc- Whoislinkedin.com
6 https://www.youtube.com/user/medicalletter Whoisyoutube.com
7 http://medicalletter.wordpress.com Whoiswordpress.com
8 https://medicalletter.wordpress.com/2024/08/06/slow-ga-with-syfovre/ Whoiswordpress.com
9 https://medicalletter.wordpress.com/2024/07/03/on-prevagen/ Whoiswordpress.com
10 https://medicalletter.wordpress.com/2024/03/18/a-new-federal-rule-regarding-tv-drug-advertisements/ Whoiswordpress.com
11 https://medicalletter.wordpress.com/2024/02/01/pushing-vaccinations/ Whoiswordpress.com
12 https://www.facebook.com/TheMedLetter Whoisfacebook.com
13 http://twitter.com/MedicalLetter Whoistwitter.com
14 https://www.instagram.com/medicalletter/ Whoisinstagram.com
15 https://www.linkedin.com/company/the-medical-letter-inc- Whoislinkedin.com
16 https://www.youtube.com/user/medicalletter Whoisyoutube.com

Medicalletter.org

Linkedin.com

Youtube.com

Email Tools

Bulk Email Verifier

Email Extractor

Extract Email From Domain

Extract Email From Website, Url

Extract Email From Text

Extract Domain From Email List

Website Tools

Link Extractor

Download Youtube Shorts

QR Code Generator